| 產(chǎn)品名稱(chēng) |
pAbt1527 |
| 商品貨號(hào) |
B215541 |
| Designations |
pAbt1527 |
| Species |
Herpes simplex virus 2 |
| Depositors |
Therion Biologics Corporation, L Gritz, Therion Biologics Corporation |
| Applications |
This clone contains a portion of the vaccinia HindIII M region and the Herpes Simplex Virus type 2 gD glycoprotein gene under the control of the vaccinia virus 40K promoter. |
| Vector |
Construct size: 5.366 |
| Insert |
Gene product: glycoprotein gD |
| Media |
ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
|
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments |
This clone contains a portion of the vaccinia HindIII M region and the Herpes Simplex Virus type 2 gD glycoprotein gene under the control of the vaccinia virus 40K promoter. |
| Classification |
Herpesvirus, Human, Simplexvirus |
| References |
Panicali DL, et al. Recombinant Pseudorabies virus. US Patent 5,242,829 dated Sep 7 1993
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
